Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Risperidone long-acting for alcohol and schizophrenia treatment (R-LAST)

Trial Profile

Risperidone long-acting for alcohol and schizophrenia treatment (R-LAST)

Phase of Trial: Phase IV

Latest Information Update: 25 Mar 2018

At a glance

  • Drugs Risperidone (Primary) ; Risperidone
  • Indications Alcoholism; Schizoaffective disorder; Schizophrenia
  • Focus Proof of concept; Therapeutic Use
  • Acronyms R-LAST
  • Most Recent Events

    • 02 Nov 2010 Actual end date (July 2010) added as reported by ClinicalTrials.gov.
    • 02 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Mar 2009 Planned end date changed from 1 Jun 2009 to 1 Jun 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top